Alfie is an AI-powered B2B digital health platform for obesity management specifically targeting patients with moderate to severe obesity by offering a comprehensive virtual obesity management clinic to help lose weight and maintain weight loss. $314k Safe funded in Q4 ’23 C0-Founder Alexander Singh |
Portfolio 2024
CAV Angels portfolio companies
These companies are group deals that CAV Angels members have invested in via special purpose LLC’s formed specifically to enable said investment. In order to justify a group deal we typically require a minimum of $250k of cumulative investor interest.
Augmented reality (AR) platform that serves the unique needs of cultural institutions and the travel industry creating dynamic, immersive Founders: Greg & Marion Werkheiser |
An Integrated GeoAI Ops Platform Series A, $750K in Q3 2022 Cofounders Brendan Richardson, Simeon Fitch, and Daniel Bailey |
Babylon Micro Farms – Sustainable indoor hydroponic farming system. Invested $585k in late’20/Q1’21seed round, $275k in a pre-Series A convertible note and $250k+ in a Series A raise in Q4 ’22 and Q4 ’23 (extension) Grand Total invested $1.1 MM. Founders: Alexander Olesen and Graham Smith |
Woman-founded app to help find cheaper alternatives to beauty/skincare products (“dupes”), launching their own line of skincare products Series Seed, Funded $600k+ Q2 2021 and $92K in Q3 2022 Founder: Meg Pryde |
Microplate reader, a fraction of the price and size of competitors, that helps scientists perform lab experiments. Series Seed, $500k in Q2 2021 Series Seed 2 equity raise $975k in Q3 ’22 and $152K in follow on in Q4 ’23. Total invested $1.627 MM Founders: Erik Hewlett, Jason Papuan and Kevin Seitte |
AI solution for remote detection of failures in home systems Series Seed , Funded $400k in 2021/22 Founders: Dan Simpkins, Chuck Gritton |
Sprayable hydrogel for cardiac adhesion prevention, a complication that arises during cardiac surgery. Series Seed, closed in Q1 ‘2022. $584k and $190k in Q1,’23. Grand total $774K. Founder: Greg Grover |
Rethinking and modernizing the world of enteral feeding. $518k Series A stock raise Q2 ’23 Founder Neal Piper |
Patented Tornadic One-Pass technology removes contaminants from industrial wastewater. Funded $300k in Q4 ’20 Seed round, $300k+ in Seed 2 Convertible note in H2 ’21 and $155k in ’23 convertible note offerings. Total invested $755k. Founders Karen Sorber & Kelly Rock |
Developing a new technology, both hardware and software to collect biometric information on domestic (dogs & cats) and production (cattle and chicken) animals for supplying animal health care $500k Q4 ’23 Convertible Note Round. |
SaaS recruiting platform for students and recruiters seeking top talent with advanced degrees Funded 2017 and 2019. Approximately $200k over multiple rounds Company shut down and investment liquidated in 12/23 |
Springbok Analytics – AI-powered solutions to provide accurate, rapid and comprehensive insight and analysis of the human musculoskeletal system. Invested $465k in December 2020 seed round and $108k in a pro-rata in Q1’23 in a Series Seed 1 raise that converted all prior notes into stock. Founders: Drs Silvia Blemkuhl, Joe Hart & Craig Meyer |
The Ross brothers deliver locally grown, fresh picked pesticide-free salads to the DC Metro/NoVa area. $218k convertible note investment into this Y-Combinator/Khosla Ventures portfolio company that came our of Uva’s iLAB. CAV’s 2nd investment in a vertical farming company. Co-Founders Michael & Jack Ross |
Brings Molecular Rotational Resonance spectroscopy to commercial applications. Funded $285k in rounds from Q3 ’20 and Q4 ’21” and $320K in Q3 ’22 |
Clockwork is an investment technology company building a proprietary platform for private investors including family offices, individual investors, networks, funds and other institutions and intermediaries. Q4 ’23 $250k funded in 1st close of SAFE convertible note. Co-Founder Alex Goodman |
Flaire: Social Media platform that enables informed decisions from a network of trusted sources Q4 ’20 Seed Round $65k, Q4 ’22 $260k and $230k Q4 ’23 Founder: Julia Carter |
Novel medical device to help patients suffering from pulmonary emboli. Series seed convertible note $325k raise closed in Q2’22. Follow-on raise of $75k in Q4 ’23. Co-Founders: John Schindler & Derek Hall |
Organic bio- pesticide to treat high value crops and control mold Pre-seed investment in 2019. Seed round in Q4 ’21 and Q4 ’22 of $275k. Total funding $375k+. |
Specialty materials – additive that strengthens polymers and composites enabling light-weighting Funded Series Seed Q3 2020 $250k and $1M Series Seed 2 raise in Q1’22 Founders: Haley & Kevin Keith |
SaaS mentoring /Mentor management platform Funded Q2 2020 and Q2 2021 Seed Rounds $315k+and $84k via convertible note in Q1’23. Total invested $400k+. Founder: John Failla |
RTM VitalSigns: Medical devices which enable remote real-time sensing, monitoring and analyzing critical patient health data. Funded $280k Seed Round November 2020 Founders Nance Dicciani, Denise Devine & Dr. Jeff Joseph |
Drug discovery – Natural Therapy for Dry Eye Total funded $1.4M over multiple rounds beginning in 2017 including $700k in 2021 bridge note Founders: Mark Logan, Gordon Laurie PhD, CEO Anil Asrani |
Medical device company addressing rapid diagnosis MTBI. Funded $586 Q3 ’23 bridge round to series B convertible note offering. |
Israeli-based spinal surgery device company pivoting to robotic surgery opportunity. Series A, $600K in December 2021 |
Autonomous underwater vehicle (UAV) not requiring a support vessel Funded Series Seed Rounds in Q1 and Q4 2020 approx $400k MONETIZED 1/22Sold to Anduril Industries Founders Jerry Sgobbo, Bill Lebo |
B2B FamTech platform enabling work/life balancing family activities. $250k equity raise Q2 ’22 and $30k follow-on in Q3 ’23 Founder : Caitlin Iseler |
AC direct LED lighting solution Funded 2017 Series Seed $250k Founder: Roger Whyte |
Drug discovery – developing a novel microRNA therapy to treat patients Funded Series Seed in Q3 2019 $300k and $200k Series Seed 2 in Q1’21 Founder: Dr. Brian Annex |
Orthopedic implant for joints that encourages the growth of new cartilage, specially designed for younger patients who want to avoid surgeries like total knee replacement. $580K in Q3 ’21 and Q3 ’22 and $329k in Q3 ’23 bridge raise. Total invested $909k Founder: Ben Holmes |
Mobile and web platform designed to bring friends together offline. Series Seed, $1.2M in Q1 2021 |
Therapeutic drug development company targeting autoimmune diseases. $727k Series Seed raise in Q2’23 Founder Andy Krouse |
Specialty pharma company developing novel oral drug delivery platform. Seed Round Investment, $212K in Q3 ‘22 |
CAV Angels Investments
These companies are group deals that CAV Angels members have invested in via special purpose LLC’s formed specifically to enable said investment. In order to justify a group deal we typically require a minimum of $250k of cumulative investor interest.
ESG marketplace connecting small businesses and consumers shopping with social impact values in mind. Funded $70k in Q4’22 Co-Founders: Bri Hart and Ben Artuso |
MedTech – developing Adam, a long-lasting, reversible male contraceptive using hydrogel technology Funded $50k+ pre-Series A bridge Founder: Kevin Eisenfrats |
Knit, f/k/a Purpics, AdTech – Helping brands engage GenZ consumers 10x more effectively Series Pre-Seed and Seed Approximately $100k 2018/19 and $30k in Q1’23 Seed Extension Round Founders: Victor Layne, Aneesh Dhawan |
O’MY Foods – Delicious dairy free gelato. Invested $180k in Dec ’20/Jan ’21 seed round for this RVA-based woman owned business Liquidated Q3 ’23 |
Sunny Day Fun: Employer-rewarded emergency savings program aiming to help stabilize workers’ finances and increase financial freedom. Seed round, $125k in August 2021 Founder: Sid Pailla |
Warehowz is an innovative on-demand warehousing solution that is revolutionizing the way businesses identify warehousing solutions. Funded $100k Q3 ’23 Founder: Darrell Jervey |
Focusing on AI augmentation targeting customer service conversations, with deployment initially in the pharma and financial institution sectors. The CAJU platform helps monitor, curate, harness, and react to social media and internal messaging communication to the benefit of regulatory compliance, and other high-profile issues like sales force performance. |
DataClassroom – STEM app graphing tool to enable key learning for middle/high school students globally. Invested $60k in a pre-seed round Q1’21 Co-founders Aaron Reedy – C’ville, VA & Dan Temple – Copenhagen, Denmark |
Navy Hill: Premium better-for -you line of cocktail mixers. Launching premium line of Ready-to-Drink tequila sodas. $200k equity investment in Q2 ’22 Cofounders Jenny Lucas and Katie Williams |
Building unique fluorescent labels to enable high resolution biology at the single cell level Funded Series Seed in 2019 approximately $200k Monetized 12/20Duke spin-out with UVA PhD CEO Mike Stadnisky |
Fin/InsurTech – Saas-based insurance underwriting platform leveraging data science, AI and machine learning Funded 2018 Series Seed approximately $100k Founders: Paul Ford, |
Empowering innovation with quality location data Acquired by Digital Envoy – rebranded to Outlogic Funded H1 2020 Approximately $800k of Bridge round to Series B |
CarpeDM: Members-only dating community and matchmaking service dedicated to finding professional Black women meaningful relationships. Pre-seed round, $60K in September 2021 Founders: Naza Shelley and Sali Hama |
Growing the circular economy by enabling peer to peer returns in both the fashion and furniture industry. Funded $70k in Q3 ’22 Closed/Liquidated Q4 ’23 |
Pre-owned bookstore offering individual titles, books by the pound, or book bundles. Pre-seed Equity Round, $105K Founder: Devan Coombes |
SaaS security platform that secures digital assets and reduces digital risk Funded in H1 2016. Founders: Jim Zuffoletti, Otavio Freire |
Brave Virtual Worlds: Wearable motion capture technology to help coaches and athletes evaluate performance. Pre-seed investment $130k cumulative investment in Q2′ and Q4’22 and Q1’23 |